Showing results (131-140 of 159) with videos related to
Sort By:
Pageof 16
Retina (Philadelphia, Pa.)|July 14, 2012
A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytesSarah L Miles, Richard M Niles, Sean Pittock, et al.Molecular Therapy Oncolytics|October 9, 2018
APOBEC3 Mediates Resistance to Oncolytic Viral TherapyAmanda L Huff, Phonphimon Wongthida, Timothy Kottke, et al.Expert Opinion on Biological Therapy|February 19, 2020
Combination therapy with oncolytic viruses and immune checkpoint inhibitorsMatthew Chiu, Edward John Lloyd Armstrong, Vicki Jennings, et al.Biorxiv : the Preprint Server for Biology|August 6, 2025
Repeat Systemic Delivery of Cross-Neutralization Resistant Synthetic Vesiculoviruses Immunomodulates the Tumor MicroenvironmentNatalie M Elliott, Benjamin L Kendall, Souyma Dutta, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2019
Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder CancerNicola E Annels, David Mansfield, Mehreen Arif, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 25, 2009
Clinical grade OK432-activated dendritic cells: in vitro characterization and tracking during intralymphatic deliveryEmma West, Ruth Morgan, Karen Scott, et al.Journal for Immunotherapy of Cancer|September 26, 2025
Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunityAndrew J Hayes, Emma J Davies, Michelle Wilkinson, et al.Journal for Immunotherapy of Cancer|March 20, 2021
Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow nicheLouise M E Müller, Gemma Migneco, Gina B Scott, et al.Journal for Immunotherapy of Cancer|July 26, 2024
Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signallingEdward Armstrong, Matthew K L Chiu, Shane Foo, et al.Nature Communications|June 26, 2020
Oncolytic virus-derived type I interferon restricts CAR T cell therapyLaura Evgin, Amanda L Huff, Phonphimon Wongthida, et al.Pageof 16